tv Nightly Business Report PBS May 4, 2016 1:00am-1:31am PDT
this is "nightly business report." with tyler mathisen and sue herera. market slide. why three factors that propelled the recent rally may be starting to reverse. costly defeat. johnson & johnson lost another talcum powder cancer case and a lot more are looming. hitting the gas. why the boom in auto sales isn't tapping the brakes just yet. >> all that and more tonight on "nightly business report" for tuesday, good evening and welcome, i'm sharon epperson in for sue herera. >> i'm tyler mathisen. global growth fears found their way back into the market today and some of the reasons for today's triple-digit decline are all too familiar. a fall in oil prices. a drop in chinese manufacturing activity. and signs that growth in the
eurozone may be weaker than previously thought. that pressured stocks. the dow jones industrial average dropped 140 points to 17,750. nasdaq fell 54. the s&p 500 was off 18. as bob pisani points out, the very things that had been driving the market higher for nearly three months seem to be starting to shift. >> reporter: stocks were down today as three key parts of the recent rally reversed a bit. first the china problem. china's been stable recently but the economic data has been choppy, kind of hard to read. overnight the manufacturing numbers were weaker than expected. and that is predictably causing commodities and commodity stocks to weaken around the world. second dlem is the dollar, notably weak this quarter. it's been a big help to commodity stocks and u.s.-based exporters. some are starting to question whether the dollar's fall is now over. indeed, the dollar staged a
reversal today. the third problem is oil. we know that it's off the february low of roughly $26. but it's dropped about 5% in the last few days as it's become clear that production is still very high among the biggest players around the world and that's unlikely to come down much. so is all this the start of something? if so it's modest so far. as with all the market leaders -- energy, materials and industrials -- are now susceptible should there be a modest pull-back, that's why they're down today. so far modest is all we're seeing. the s&p 500 was at 2,100 at the end of april. so we're only 2% off of that. so far this is a modest garden variety pullback. not even a correction. at least so far. for "nightly business report," i'm bob pisani at the new york stock exchange. an interest rate hike in june is a real possibility so that the president of the atlanta fed says. dennis lockhart says financial markets may be underestimating
the prob tilt of a central bank rate hike next month. the odds were halved when the fed signaled little urgency to teigen. americans' appetite to cars and trucks remains strong, healthy sales for the month of april. as had been the case pickups and suvs are the models most in demand. phil lebeau explains why auto purchasers are back on track. >> reporter: as the weather warms so have auto sales. with three of the country's four largest automakers reporting a slight pickup in sales. speaking of pickups, sales of the chevy silverado and ford f-150 remain red hot as do sales of suvs which are benefitting from relatively low gas prices and americans continuing to pass up buying a car in favor of a bigger crossover or suv which offers more space and utility. while automakers offered greater incentives to entice buyers last month the deals were offset by
consumers paying more. true car says the average vehicle now sells for more than $33,000. with the sales pace for april topping 17 million vehicles the industry remains on pace to match or maybe even exceed last year's record run. from now through august, will likely be the busiest stretch of the year for auto dealers. if consumer confidence remains high, this could be a record summer for the auto industry. "nightly business report," chicago. reports this evening that cada is preparing to recall at least another 35 million air bag inflaters. as first reported by "wall street journal," regulators have deemed these inflaters a safety risk. the recall could affect tens of millions of cars in all and will likely be made official this week. new drugs for cancer and arthritis helped pfizer report a solid quarter and top earnings expectations. the largest drugmaker in the u.s. also raised its revenue and
earnings forecast for the year. the company signing the weakening dollar as part of the reason for the improved outlook. ceo ian lead said the company is considering a potential separation of its innovative and established businesses following the abandonment of its $160 deal for allergan last month. pfizer shares rose more than 2.5%. martin chiarelli appeared in court today where prosecutors told a federal judge they were considering additional fraud charges. he's known for raising the price of a decades-old medication. but this case relates to alleged securities fraud and conspiracy to commit securities fraud during his time as ceo of the pharmaceutical company retrofin. he was arrested late last year. johnson & johnson is facing a growing threat of losses related to a product that many of us have or have used in the past, talcum powder.
a jury ruled against the pharmaceutical company for the second time in three months. bertha coombs looks at the legal issue and potential risk for j&j shareholders. >> reporter: johnson & johnson's baby powder has been one of the company's iconic products for more than a century. but now j&j faces more than $100 million in damages and potentially a lot more from lawsuits claiming its talcum causes cancer in women. monday a jury awarded $55 million to a south dakota woman who claimed j&j's baby powder caused her ovarian cancer. three months after a $77 million award to the family of jacqueline fox who died of ovarian cancer four months before that trial. plaintiffs argued cot was aware of studies which raised an association between the use of talcum powder used for personal hygiene and cancer. but in court and in a video statement on its website, j&j cites research which finds no cancer link.
>> the safety of talc is based on more than 30 years of data generated by authoritative researchers. we are confident in our position that there's no causal association between talling and ovarian taken. >> reporter: the company says it will appeal the jury awards but there are more than 1,000 cases pending of women claiming they contracted ovarian cancer after using its baby powder for decades. eric gordon of university of michigan thinks it's likely the company may move to settle eventually. >> johnson & johnson is going to maintain till the end that the product is safe, but i think the strategy of how you handle these cases is going to change. it's time for them to seriously think about settling as many of the remaining cases as they can. >> reporter: analysts say for investors the lawsuits don't present a large risk for now. the company's consumer division makes up less than 20% of its business. more losses could pose a pr problem for j&j.
>> so this isn't some technical, scientific medical device that nobody really understands. this is something most of us have had in our bathrooms. the possibility that it could cause cancer is a real blow to the brand. >> reporter: that could pose a big problem in the court of public opinion even if the data is mixed. for "nightly business report," i'm bertha coombs. let's turn to our guest to talk more about what all this ultimately might mean for johnson & johnson and how it could impact you and your money. katherine sharky is a law professor at new york university and marshall gordon is portfolio manager with clear bridge investments. ms. sharky, i can't imagine anything more damaging potentially to a brand and a company than an accusation which has now been supported by two juries that a product causes cancer. do they have to take this product off the market immediately? or risk really even bigger
judgments against it? >> they certainly do have a public relations issue on their hands. this is not only an iconic product, one that many consumers have in their bathrooms, but it also has associations. omni present in the nursery, brand loyalty with women who continue to use this product after their babies have grown. there's that dimension to it. whether they will decide to settle these lawsuits as a result of this public relations issue remains to be seen. >> marshall, it of course is a public relations fiasco here. and brand damaging. but what about for investors who may own johnson & johnson? what impact will that have for them? >> i don't see this as particularly consequential to the overall picture of johnson & johnson. unfortunately, lawsuits are really part of doing business in
the medical world today. and health care world. and for a company as large and as diversified as j&j, this is a company with a $70 billion sales each year, about $1 billion or more in free cash flow per month. and $300 billion of market cap. they can absorb what i think will eventually be a relatively modest settlement. and really won't impact investors terribly much. >> really? i mean, this goes right at the heart of the company's integrity, doesn't it, marshall? in other words, if they are selling a product to women and mothers that is a -- has a carry-causing risk? that could seem to me to be a very serious threat to their basic image. >> well, i do believe that they
need to be very careful about how they handle this situation. to avoid damage to their image. one thing that i would tell you is that this is a company that has been very adept at managing situations in the past. and if you look at j&j's very long history, look at what they did with tylenol many years ago. that was a major risk to the business. and they had turned that recall around into something where they became an industry leader in safety. so i think it really -- i do acknowledge that there's a risk but i think the j&j management team is capable of navigating this. and they need to tread carefully to maintain the company's image and limit the damage to consumer brands. >> katherine, there are 1,400 or so pending lawsuits.
there's still quite a bit unknown out there about how much damage may be in the future for j&j just based on this alleged connection between talc and ovarian cancer. could that potentially be an even greater risk and a greater investment risk because we don't know the outcome of those verdicts? >> it could. i guess the point that i would hit is there was a component here of a punitive damages award. so the jury in this case found not only that the product caused cancer, not only in some generic sense but in the particular situation, but they awarded punitive damages. they awarded $50 million of this verdict in punitive damages, which is supposed to be for particularly reprehensible conduct. and my understanding is that companies will often go to pretty great lengths to settle out cases, to pay maybe larger awards in damages, to avoid having punitive damages. because that can take a real
reputational hit for those. >> katherine sharky with new york university school of law, marshall gordon with clear bridge investments, thanks very much. >> thank you. still ahead, beating the odds. the big money behind the unlikeliest of winners. donald trump and hillary clinton are hoping indiana voters help them seal the nomination. ted cruz and bernie sanders are looking to indiana to give their
campaigns some hope. john harwood is in washington with a look at this critical primary. john, how high are the stakes tonight? >> they're especially high on the republican side. because the stop trump forces have been looking to indiana as the place they could plant their flag and say, if we can beat him here, we can complicate his path to getting the 1237 delegates he needs for a first ballot nomination. if they can't do it, if donald trump wins tonight, that suggests that the opposition is collapsing to trump and that by the time he gets to the california primary on june the 7th that he has the potential to go over that number that he needs. on the democratic side, it's pretty clear hillary clinton's going to be the nominee. bernie sanders almost openly concedes that. so the stakes are lower on the democratic side. polling has been close. hillary clinton's had a slight lead. >> how, particularly on the gop side, have the candidates been handling the pressure as we get down to the wire? >> not very well. this campaign in the last 24
hours has really gone off the rails. you've had donald trump raising the specter of a completely unsubstantiated "national enquirer" story suggesting ted cruz's father, who emigrated from cuba, might have somehow associated with lee harvey oswald, the assassin of john f. kennedy. of course, rafael cruz denies that. and ted cruz went off on trump today, said he was a pathological liar, said he had been a fearial philanderer. it got ugly in this race and suggests it's going to be difficult to bring the party together, if in fact trump is able to nail down that republican nomination. >> is it possible, john, that the outcome of tonight will let us know that the general election is really beginning that campaign is really beginning tomorrow? >> i think so. that's certainly the indication that we've gotten from both the trump and clinton campaigns. they believe it's moving in that direction. i got to tell you, this is going to be a nasty general election campaign over the next several
months. not an appetizing spectacle because you've got two potential nominees, if in fact they do emerge as the nominees, with very high negative ratings, very skeptical public looking at them, the opponents are going to try to max myself those doubts in the public's mind. >> unappetizing as it may be, we'll be watching very closely. john harwood, thank you. cbs gets a super bowl boost and that is where we begin "market focus." first quarter earnings rose 20% topping expectations. strong super bowl ad sales the reason. ceo les munvez says he expects more growth in advertising later this year as political spending increases closer to the political election, appetizing or not. shares of cbs rose initially next tended trading finished the regular session down more than 1% to 55.65. revenue rose by 19% at the drugstore chain cvs. results lifted by strong sales in the the company's specialty prescription drug unit.
cvs reaffirmed its full year profit forecast but said it expects next quarter's earnings to fall below expectations. shares up more than 2%, they finished at 1 owe 3.92. "new york times" reported a loss for the first three months of 2016. revenues also declined. but not by as much as analysts had feared. digital subscriptions rose in the quarter and the ceo remains confident in the company's ability to grow its digital ad revenue. shares did fall more than 3% on the day to 12.45. biotech company biogen will spin off its hemophilia drug business into a publicly traded company a move biogen said will create the best value for shareholders. the spinoff expected to be completed by later this year or early next. shares of biogen closed flat at 273.71. tyler, sprint reported a wider than expected loss for the latest quarter ath added fewer subscribesers than analysts expected. the wireless phone provider
plans to trim more than $2 billion in costs this the year, a move that prompted the company to raise its guidance for the full year operating income. shares were up 5% to 3.67. low commodity prices continued to weigh on oil field service provider halliburton, as the company reported losses in profit and revenue. after a failed merger with baker hughes halliburton said it would consider other acquisitions in the future. shares were off nearly 4% to 40.44. metlife has agreed to paid $25 million to settle an investigation by a securities industry regulator in which the company allegedly made misrepresentations to customers regarding variable annuities. as part of the settlement metlife neither admitted nor denied the charges. shares fell 2% to 44.79. an incredible triumph in the sports world. leicester city football club overcame 5,000 to 1 preseason odds to clinch the english
premier league title, one of the greatest upsets in sporting history. especially for a team with a payroll a fraction the size of its rivals. discussing the money behind the victory, let's start with those who placed a bet on lester before the year started. i assume that most of the sports books, the house always wins because it was more money moving on the favored clubs like chelsea or man city, man united. but they had to lose a lot of money on leicester city. >> they had to lose a lot of money on leicester city. if you put $20, you win $100,000. so it just takes a few people to do this and blow it up for the bookmakers. in fact, the bookies we talked to, not the street bookies, guys that are running real operations, william hill in the u.s., in england, lost six figures in the u.s. on all of their english soccer. so even all the games that they got on everyone else getting it wrong, they still lost a lot of money.
numbers in england, about $20 million or more. that's what they'll admit. they say eight figures, it could be up to $100 million in losses just so soccer. >> what about the players on the team, the ones making a fraction of what players on other teams were making any heard by one account there's one player on manchester united that's probably making as much as the entire team. >> that's true. >> how did they fare? >> manchester united spent more in the last couple of years on players than leicester city has spent in the entire 130 years they've been around. they have a good scouting department and they found people that other teams didn't want. they were able to get them for cheap. they were playing in other countries, other leagues, lower-division teams. they turned them into value. this is a story about deep value and turning a profit. >> you're telling me. two questions in one here. what do we know or can we surmise anything about the value of leicester city as a franchise and have there ever been comparable long shots, payoffs like this? >> the team's owned by a group of thailand investors.
by winning the league they get to be in the champions league, they get more money for that, they get tv money next year. $100 million is probably increasing the value of the team. just in terms of next year's revenues. if they can repeat next year that will be the story. we've never -- >> competitive, yeah. >> we've never seen a long shot like this before. this was an entire season, not just a playoff. 100-1, those were the odds uconn had when winning the ncaa tournament but they had just to win six games. you can have a good month or two but it's hard to have it for an entire season, an entire year. >> fabulous story, thanks very much. it's where sports and fashion collide. but not everyone comes out a winner.
grocery chain fairway has filed for chapter 11 bankruptcy protection. the company cited competition from other supermarkets including whole foods and trader joe's as well as online shopping and an aggressive expansion plan. the retailer plans to exit bankruptcy soon as it revamps its balance sheet. arrow postal reportedly preparing to file for bankruptcy according to the "wall street e chapter 11 protection in the next few days. the retailer would close more than 100 of its 800 stores soon after that filing. rival teen retailer pacific
sunwear sought bankruptcy protection last month. sports authority isn't fully liquidating yet. attorneys for the sporting goods retailer told a federal judge the retail chain which filed for bankruptcy protection last month is still pursuing a sale process. last week the company's attorney said sports authority would not emerge under a reorganization plan. while sports authority is one of a handful of athleticwear retailers to come under pressure, some are in much better shape. courtney reagan explains. >> reporter: sales of traditional apparel continue to be sluggish. sales of sports equipment, leisure, continue to grow. but not all retailers that sell athletic apparel and equipment are thriving. sports authority, eastern mountain sports, and shorts l.a. are filing for abruptly. rei, nike, north face are among the outperformers. there are a number of factors separating the all-stars and those on the disabled list.
first many of the athletic brands own websites and stores are hurting sales of their goods at retailers like sports authority. for instance, you can only customize a pair of nikes on nike's website. second, off-price options like tj maxx and outlets offer consumers lower prices on athletic merchandise. plus department stores like macy's, jcpenney, and others offer their own athleticwear brands for often lower prices. also, sports authority, eastern mountain, and sports chalet are privately run and laden with debt, making restructuring harder than it could be with public competitors. perhaps the most important connecting the consumer to an experience. like being a part of the community of dedicated athletes plays a bigger role in selling athletic wear and equipment than it does in other areas of retail. >> the game has changed. it's not about having a brick and mortar store and putting a commercial on tv and selling the product. i think now it's really becoming, to sell the product, you need to be part of their
everyday lifestyle, the cost of doing business so much higher. to do this you have to spend the money and be ahead of the game. that's what i think the nike, under armours, i think that's why they're capitalizing. >> reporter: consumers spend time in lulu lemon stores. not only to buy yoga pants but to practice yoga too. nike and under armour have sophisticated apps to guide a consumer's lifestyle and insert product recommendations as well. at rei shoppers are shareholders in the business. 2015 was a record year for both. the purchasing literally pays them back in the form of an annual dividend. for "nightly business report," i'm courtney and finally tonight, history is made on broadway. "hamilton," the hip-hop musical about america's founding father, picked up 16 tony award nominations. that breaks the record set by "the producers" in 2001 and "billy elliot" in 2009. as of last month the show has
grossed more than $60 million at the box office. since broadway previews began last july, according to "billboard" magazine. premium tickets sell for about $550 each. >> i think the show is why hamilton is staying on the bill. >> so wonderful. it is just -- such an impact. >> it's amazing. >> amazing show. that's "nightly business report" for tonight. i'm sharon epperson. thanks so much for watching. >> i'm tyler mathisen. see "hamilton" if you can. have a great evening, see you tomorrow.
narrator: tonight on "spark," arts and social issues. bay area artists and designers breathe new life into san francisco's neglected urban corridor. cullinan: what if you walked to work every day? and it was fun? i mean, why not? right? narrator: with spellbinding views from the sky, a bay area photographer reveals mankind's scars on the land. hundreds of thousands of people experience chinese artist ai weiwei's ground-breaking installation on alcatraz. [ wood blocks tapping rhythmically ] an experimental setting for new music and classical greats. inside san francisco symphony's soundbox. thomas: extraordinary to think that something 400 years old could have that powerful effect on someone who's a 21st-century person. narrator: it's all ahead on "spark." funding for kqed arts is provided by...